Viemed Healthcare, Inc.(VMD)Earnings, Financials & Key Ratios

VMD•NASDAQ

$9.21

$353M mkt cap·24.9× P/E·Price updated May 7, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryRespiratory and sleep therapy devices

AboutViemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.Show more

Revenue$270M+20.5%
EBITDA$49M+14.0%
Net Income$15M+32.6%
EPS (Diluted)0.37+32.1%
Gross Margin57.52%-3.2%
EBITDA Margin18.25%-5.4%
Operating Margin7.66%-4.0%
Net Margin5.53%+10.0%
ROE10.79%+18.4%
ROIC11.57%+0.8%
Debt/Equity0.11+115.7%
Interest Coverage19.42-11.1%

Technical→

VMD Key Insights

Viemed Healthcare, Inc. (VMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Momentum leader: RS Rating 83 (top 17%)
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 15.5%
✓Efficient asset utilization: 1.3x turnover

✗Weaknesses

✗Profits declining 13.9% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

VMD Price & Volume

Viemed Healthcare, Inc. (VMD) stock price & volume — 10-year historical chart

Loading chart...

VMD Growth Metrics

Viemed Healthcare, Inc. (VMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years22.82%

5 Years15.53%

3 Years24.87%

TTM23.1%

Profit CAGR

10 Years5.28%

5 Years-13.88%

3 Years33.89%

TTM21.19%

EPS CAGR

10 Years-13%

5 Years-14.71%

3 Years35.11%

TTM25.92%

Return on Capital

10 Years21.84%

5 Years12.07%

3 Years13.27%

Last Year13.21%

VMD Recent Earnings

Viemed Healthcare, Inc. (VMD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 3/12 qtrs (25%)●Beat Revenue 5/12 qtrs (42%)

Q2 2026Latest

May 5, 2026

EPS

$0.06

Est $0.09

-33.3%

Revenue

$75M

Est $74M

+1.4%

Q2 2026

Mar 4, 2026

EPS

$0.14

Est $0.12

+16.7%

Revenue

$76M

Est $78M

-2.0%

Q4 2025

Nov 5, 2025

EPS

$0.09

Est $0.09

+0.0%

Revenue

$72M

Est $78M

-7.4%

Q3 2025

Aug 6, 2025

EPS

$0.08

Est $0.09

-5.9%

Revenue

$63M

Est $64M

-0.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$0.06vs $0.09-33.3%	$75Mvs $74M+1.4%
Q2 2026	Mar 4, 2026	$0.14vs $0.12+16.7%	$76Mvs $78M-2.0%
Q4 2025	Nov 5, 2025	$0.09vs $0.09+0.0%	$72Mvs $78M-7.4%
Q3 2025	Aug 6, 2025	$0.08vs $0.09-5.9%	$63Mvs $64M-0.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
LINCLincoln Educational Services CorporationProduct Competitor	1.39B	44.10	67.85	17.76%	3.86%	10.01%	1.02
BRTBRT Apartments Corp.Product Competitor	277.12M	14.72	-22.31	1.46%	-12.52%	-6.77%	2.87
EHABEnhabit, Inc.Product Competitor	705.89M	13.78	-152.10	2.44%	-0.3%	-0.56%	0.89
HCSGHealthcare Services Group, Inc.Product Competitor	1.6B	22.31	27.54	7.08%	3.21%	11.83%	0.05
ADUSAddus HomeCare CorporationProduct Competitor	1.81B	97.29	18.67	23.21%	6.89%	9.34%	0.19
INSPInspire Medical Systems, Inc.Supply Chain	1.31B	45.57	9.32	13.6%	14.33%	17.98%	0.04
NVCRNovoCure LimitedSupply Chain	1.92B	16.83	-13.80	8.28%	-25.66%	-50.82%	0.85
PHGKoninklijke Philips N.V.Supply Chain	25.84B	27.16	24.85	-1.04%	5.02%	8.19%	0.74

Compare VMD vs Peers

Viemed Healthcare, Inc. (VMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LINC

Most directly comparable listed peer for VMD.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare VMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs LINC, BRT, EHAB, HCSG

VMD Income Statement

Viemed Healthcare, Inc. (VMD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	46.93M	65.27M	80.26M	131.31M	117.06M	138.83M	183.01M	224.26M	270.28M	286.56M
Revenue Growth %	49.66%	39.09%	22.96%	63.61%	-10.85%	18.6%	31.82%	22.54%	20.52%	23.1%
Cost of Goods Sold	12.31M	16.69M	24.25M	51.2M	43.65M	54.15M	70.22M	91.05M	114.82M	121.91M
COGS % of Revenue	26.24%	25.57%	30.22%	38.99%	37.29%	39.01%	38.37%	40.6%	42.48%	-
Gross Profit	34.62M▲ 0%	48.58M▲ 40.3%	56.01M▲ 15.3%	80.11M▲ 43.0%	73.41M▼ 8.4%	84.68M▲ 15.4%	112.78M▲ 33.2%	133.2M▲ 18.1%	155.46M▲ 16.7%	164.65M▲ 0%
Gross Margin %	73.76%	74.43%	69.78%	61.01%	62.71%	60.99%	61.63%	59.4%	57.52%	57.46%
Gross Profit Growth %	83.55%	40.35%	15.28%	43.04%	-8.36%	15.35%	33.19%	18.11%	16.71%	-
Operating Expenses	20.65M	31.54M	47.15M	53.33M	61.83M	76.43M	98.45M	115.3M	134.75M	137.91M
OpEx % of Revenue	44%	48.32%	58.75%	40.61%	52.82%	55.05%	53.8%	51.42%	49.85%	-
Selling, General & Admin	20.25M	30.95M	45.27M	57.71M	60.04M	73.36M	93.73M	112.48M	130.5M	134.5M
SG&A % of Revenue	43.14%	47.42%	56.4%	43.95%	51.29%	52.84%	51.22%	50.16%	48.28%	-
Research & Development	0	0	848K	1.08M	2.11M	2.7M	2.78M	3.07M	3.02M	2.8M
R&D % of Revenue	-	-	1.06%	0.82%	1.8%	1.94%	1.52%	1.37%	1.12%	-
Other Operating Expenses	402K	-71K	1.03M	-5.46M	-323K	369K	1.94M	-249K	1.23M	607K
Operating Income	8.82M▲ 0%	17.05M▲ 93.2%	8.86M▼ 48.0%	26.78M▲ 202.4%	11.58M▼ 56.8%	8.25M▼ 28.7%	14.33M▲ 73.7%	17.9M▲ 24.9%	20.71M▲ 15.7%	23.59M▲ 0%
Operating Margin %	18.8%	26.11%	11.04%	20.4%	9.89%	5.94%	7.83%	7.98%	7.66%	8.23%
Operating Income Growth %	2203.92%	93.17%	-48.04%	202.37%	-56.76%	-28.74%	73.65%	24.91%	15.7%	-
EBITDA	11.37M	20.83M	15.26M	36.36M	22.89M	23.88M	36.19M	43.27M	49.32M	45.97M
EBITDA Margin %	24.22%	31.91%	19.01%	27.69%	19.56%	17.2%	19.78%	19.29%	18.25%	16.04%
EBITDA Growth %	529.05%	83.23%	-26.75%	138.34%	-37.05%	4.32%	51.55%	19.55%	13.99%	1.64%
D&A (Non-Cash Add-back)	2.54M	3.78M	6.4M	9.58M	11.31M	15.63M	21.86M	25.37M	28.61M	22.39M
EBIT	8.82M	10.11M	9.11M	26.87M	12.82M	9.19M	14.81M	16.95M	22.95M	19.11M
Net Interest Income	-272K	-181K	-314K	-509K	-318K	-197K	-424K	-776K	-1.18M	-1M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	272K	181K	314K	509K	318K	197K	424K	776K	1.18M	1.31M
Other Income/Expense	-633K	-386K	-61K	-418K	923K	738K	61K	-1.73M	1.06M	-1.49M
Pretax Income	8.19M▲ 0%	10.34M▲ 26.2%	8.8M▼ 14.9%	26.36M▲ 199.7%	12.5M▼ 52.6%	8.99M▼ 28.1%	14.39M▲ 60.1%	16.17M▲ 12.4%	21.77M▲ 34.6%	22.1M▲ 0%
Pretax Margin %	17.45%	15.84%	10.96%	20.08%	10.68%	6.48%	7.86%	7.21%	8.05%	7.71%
Income Tax	15K	162K	271K	-5.17M	3.38M	2.77M	4.15M	4.76M	6.39M	6.72M
Effective Tax Rate %	0.18%	1.57%	3.08%	-19.6%	27.01%	30.79%	28.82%	29.44%	29.36%	30.4%
Net Income	8.18M▲ 0%	10.18M▲ 24.5%	8.53M▼ 16.2%	31.53M▲ 269.9%	9.13M▼ 71.1%	6.22M▼ 31.8%	10.24M▲ 64.6%	11.27M▲ 10.0%	14.93M▲ 32.6%	14.89M▲ 0%
Net Margin %	17.42%	15.59%	10.62%	24.01%	7.8%	4.48%	5.6%	5.02%	5.53%	5.2%
Net Income Growth %	565.8%	24.47%	-16.23%	269.85%	-71.06%	-31.82%	64.63%	9.98%	32.57%	21.19%
Net Income (Continuing)	8.18M	9.51M	8.53M	31.53M	9.13M	6.22M	10.24M	11.41M	15.38M	15.25M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	1.91M	1.98M	1.93M
EPS (Diluted)	0.22▲ 0%	0.26▲ 18.2%	0.22▼ 15.4%	0.82▲ 272.7%	0.22▼ 73.2%	0.15▼ 31.8%	0.25▲ 66.7%	0.28▲ 12.0%	0.37▲ 32.1%	0.37▲ 0%
EPS Growth %	579.01%	18.18%	-15.38%	272.73%	-73.17%	-31.82%	66.67%	12%	32.14%	25.92%
EPS (Basic)	0.22	0.27	0.23	0.86	0.23	0.15	0.27	0.29	0.38	-
Diluted Shares Outstanding	37.97M	39.68M	39.75M	40.53M	40.68M	39.81M	40.38M	40.8M	40.82M	40.49M
Basic Shares Outstanding	37.91M	37.89M	37.72M	38.74M	39.49M	38.66M	38.35M	38.76M	38.9M	38.43M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

VMD Balance Sheet

Viemed Healthcare, Inc. (VMD) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	17M	22.96M	27.81M	47.17M	47.31M	39.74M	38.37M	52.88M	48.49M	49.81M
Cash & Short-Term Investments	5.1M	10.41M	13.36M	30.98M	28.41M	16.91M	12.84M	17.54M	13.5M	9.76M
Cash Only	5.1M	10.41M	13.36M	30.98M	28.41M	16.91M	12.84M	17.54M	13.5M	9.76M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	9.78M	8.84M	11.53M	12.37M	14.72M	15.4M	18.45M	24.91M	25.59M	31.18M
Days Sales Outstanding	76.08	49.43	52.46	34.39	45.88	40.5	36.8	40.55	34.55	35.87
Inventory	1.63M	2.89M	1.36M	2.31M	2.46M	3.57M	4.63M	4.32M	5.05M	5.18M
Days Inventory Outstanding	48.41	63.14	20.47	16.47	20.54	24.09	24.05	17.32	16.04	14.84
Other Current Assets	0	0	0	0	0	3.85M	2.45M	6.11M	4.36M	3.69M
Total Non-Current Assets	20.69M	30.56M	54.78M	65.39M	70.65M	77.3M	116.53M	124.19M	166.45M	147.55M
Property, Plant & Equipment	20.69M	30.56M	54.77M	55.06M	62.85M	68.44M	76.85M	79.16M	82.36M	79.31M
Fixed Asset Turnover	2.27x	2.14x	1.47x	2.39x	1.86x	2.03x	2.38x	2.83x	3.28x	3.49x
Goodwill	0	0	0	0	0	0	29.77M	32.99M	58.94M	58.94M
Intangible Assets	0	0	0	0	0	0	567K	848K	1.28M	1.22M
Long-Term Investments	0	0	13K	733K	2.16M	4.16M	3.9M	2.79M	2.79M	11.18M
Other Non-Current Assets	0	0	0	863K	862K	1.59M	887K	0	15.79M	15.79M
Total Assets	37.69M▲ 0%	53.52M▲ 42.0%	82.6M▲ 54.3%	112.56M▲ 36.3%	117.96M▲ 4.8%	117.04M▼ 0.8%	154.9M▲ 32.3%	177.07M▲ 14.3%	214.94M▲ 21.4%	197.36M▲ 0%
Asset Turnover	1.25x	1.22x	0.97x	1.17x	0.99x	1.19x	1.18x	1.27x	1.26x	1.43x
Asset Growth %	52.73%	42.01%	54.31%	36.28%	4.8%	-0.78%	32.34%	14.32%	21.39%	64.18%
Total Current Liabilities	13.15M	16.98M	25.91M	23.02M	17.81M	18.86M	32.12M	37.33M	41.06M	40.71M
Accounts Payable	3.39M	5.88M	5.72M	3.35M	5.25M	4.9M	7.41M	5.32M	7.33M	8.57M
Days Payables Outstanding	100.37	128.69	86.14	23.87	43.9	33.05	38.51	21.33	23.31	27.82
Short-Term Debt	0	0	1.75M	1.84M	1.48M	0	1.07M	409K	2.29M	2.07M
Deferred Revenue (Current)	5.22M	152K	3.31M	3.41M	3.75M	4.62M	6.21M	6.69M	7.52M	30M
Other Current Liabilities	300K	-2.11M	3.13M	4.49M	2.34M	3.19M	6.52M	0	23.91M	11.68M
Current Ratio	1.29x	1.35x	1.07x	2.05x	2.66x	2.11x	1.19x	1.42x	1.18x	1.18x
Quick Ratio	1.17x	1.18x	1.02x	1.95x	2.52x	1.92x	1.05x	1.30x	1.06x	1.06x
Cash Conversion Cycle	24.11	-16.12	-13.21	26.99	22.53	31.54	22.34	36.53	27.29	22.88
Total Non-Current Liabilities	798K	1.51M	12.98M	7.85M	5.33M	1.09M	8.88M	6.44M	30.37M	10.86M
Long-Term Debt	0	0	7.63M	5.8M	4.31M	0	6M	3.59M	11.29M	8.33M
Capital Lease Obligations	798K	394K	3.04M	762K	268K	199K	2.32M	2.01M	2.36M	8.5M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	15.79M	15.79M
Other Non-Current Liabilities	0	1.12M	2.32M	1.29M	757K	889K	558K	846K	922K	2.64M
Total Liabilities	13.95M	18.49M	38.9M	30.87M	23.14M	19.95M	41M	43.77M	71.42M	51.56M
Total Debt	5.18M	3.42M	19.51M	11.13M	6.52M	694K	10.32M	6.87M	15.95M	12.44M
Net Debt	81K	-6.99M	6.16M	-19.85M	-21.89M	-16.22M	-2.52M	-10.67M	2.45M	2.67M
Debt / Equity	0.22x	0.10x	0.45x	0.14x	0.07x	0.01x	0.09x	0.05x	0.11x	0.11x
Debt / EBITDA	0.46x	0.16x	1.28x	0.31x	0.28x	0.03x	0.29x	0.16x	0.32x	0.27x
Net Debt / EBITDA	0.01x	-0.34x	0.40x	-0.55x	-0.96x	-0.68x	-0.07x	-0.25x	0.05x	0.05x
Interest Coverage	32.44x	55.86x	29.01x	52.79x	40.32x	46.63x	34.94x	21.84x	19.42x	14.61x
Total Equity	23.74M▲ 0%	35.03M▲ 47.5%	43.7M▲ 24.7%	81.69M▲ 86.9%	94.82M▲ 16.1%	97.09M▲ 2.4%	113.89M▲ 17.3%	133.3M▲ 17.0%	143.52M▲ 7.7%	145.8M▲ 0%
Equity Growth %	84.35%	47.54%	24.74%	86.94%	16.07%	2.4%	17.3%	17.04%	7.67%	38.02%
Book Value per Share	0.63	0.88	1.10	2.02	2.33	2.44	2.82	3.27	3.52	3.60
Total Shareholders' Equity	23.74M	35.03M	43.7M	81.69M	94.82M	97.09M	113.89M	131.39M	141.54M	143.86M
Common Stock	67K	71K	3.37M	9.18M	14.01M	15.12M	18.7M	23.36M	16.91M	20.81M
Retained Earnings	20.99M	29.57M	34.11M	65.64M	73.33M	69.85M	79.5M	89.69M	102.89M	105.47M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-5.73M	-8.82M	-157K	-451K	-278K	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	1.91M	1.98M	1.93M

VMD Cash Flow Statement

Viemed Healthcare, Inc. (VMD) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	12.02M	22.37M	19.09M	35.11M	22.49M	27.75M	45.21M	39.09M	51.92M	51.92M
Operating CF Margin %	25.62%	34.27%	23.78%	26.74%	19.22%	19.99%	24.7%	17.43%	19.21%	-
Operating CF Growth %	87.46%	86.03%	-14.67%	83.95%	-35.93%	23.36%	62.94%	-13.54%	32.81%	270.3%
Net Income	8.18M	10.18M	8.53M	31.53M	9.13M	6.22M	10.24M	11.41M	14.93M	14.89M
Depreciation & Amortization	2.54M	3.78M	6.4M	9.58M	11.31M	15.63M	21.86M	25.37M	28.61M	29.62M
Stock-Based Compensation	828K	2.7M	3.89M	4.88M	5.15M	5.2M	5.85M	6.29M	9.13M	9.27M
Deferred Taxes	0	0	0	-8.73M	3.88M	1.75M	-1.44M	-3.84M	3.11M	3.11M
Other Non-Cash Items	5.34M	6.45M	9.81M	8.05M	6.58M	9.08M	921K	-488K	-1.57M	-4.17M
Working Capital Changes	-4.87M	-748K	-9.53M	-10.2M	-13.56M	-10.13M	7.78M	355K	-2.3M	4.14M
Change in Receivables	-10.13M	-5.25M	-12.51M	-9.96M	-7.34M	-12.57M	-1.08M	-6.07M	1.16M	-2.56M
Change in Inventory	5K	-1.25M	-306K	-2.3M	-212K	301K	-480.65K	574K	59K	113K
Change in Payables	900K	2.5M	783K	213K	133K	-318K	-874.75K	359K	479K	-697K
Cash from Investing	-3.57M	-5.3M	-12.81M	-8.41M	-19.75M	-23.98M	-52.11M	-30.7M	-50.17M	-47.12M
Capital Expenditures	-4M	-6.11M	-13.38M	-13.04M	-19.74M	-22.9M	-26.09M	-37.77M	-39.98M	-31.21M
CapEx % of Revenue	8.53%	9.37%	16.68%	9.93%	16.87%	16.49%	14.26%	16.84%	14.79%	-
Acquisitions	430K	813K	587.34K	-629K	-599K	-141K	-28.59M	-3M	-26.33M	-19.93M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	430K	813K	-13.34K	5.26M	596K	1.06M	2.57M	9.32M	16.15M	4.02M
Cash from Financing	-7.69M	-11.75M	-3.33M	-9.07M	-5.32M	-15.27M	2.83M	-3.69M	-5.79M	-10.41M
Debt Issued (Net)	-7.69M	-10.16M	-2.21M	-10.95M	-4M	-5.84M	2.12M	-3.41M	8.15M	8.37M
Equity Issued (Net)	0	-1.59M	-1.52M	0	-1.43M	-9.71M	-594K	-1.07M	-11.79M	-11.97M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	-1.59M	-1.52M	0	-1.43M	-9.71M	-594K	-1.07M	-13.22M	-13.33M
Other Financing	0	4K	396K	1.88M	112K	283K	1.3M	789K	-2.16M	-6.81M
Net Change in Cash	759K▲ 0%	5.32M▲ 600.3%	2.94M▼ 44.6%	17.63M▲ 499.1%	-2.57M▼ 114.6%	-11.49M▼ 346.7%	-4.08M▲ 64.5%	4.7M▲ 215.4%	-4.04M▼ 185.9%	-398K▲ 0%
Free Cash Flow	8.02M▲ 0%	16.25M▲ 102.6%	5.7M▼ 64.9%	22.07M▲ 287.0%	2.75M▼ 87.5%	4.85M▲ 76.3%	19.12M▲ 294.2%	1.32M▼ 93.1%	11.93M▲ 805.2%	25.92M▲ 0%
FCF Margin %	17.09%	24.9%	7.1%	16.8%	2.35%	3.49%	10.45%	0.59%	4.41%	9.04%
FCF Growth %	69.22%	102.64%	-64.92%	286.99%	-87.53%	76.3%	294.21%	-93.11%	805.24%	499.98%
FCF per Share	0.21	0.41	0.14	0.54	0.07	0.12	0.47	0.03	0.29	0.29
FCF Conversion (FCF/Net Income)	1.47x	2.20x	2.24x	1.11x	2.46x	4.46x	4.41x	3.47x	3.48x	1.74x
Interest Paid	0	193K	333K	559K	351K	0	851K	950K	0	749K
Taxes Paid	0	151K	338K	3.31M	1.77M	0	3.57M	6.83M	0	4.43M

VMD Key Ratios

Viemed Healthcare, Inc. (VMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	44.65%	34.63%	21.66%	50.29%	10.34%	6.48%	9.71%	9.11%	10.79%	10.52%
Return on Invested Capital (ROIC)	34.06%	49.29%	17.05%	35.96%	12.89%	8.05%	11.18%	11.47%	11.57%	11.57%
Gross Margin	73.76%	74.43%	69.78%	61.01%	62.71%	60.99%	61.63%	59.4%	57.52%	57.46%
Net Margin	17.42%	15.59%	10.62%	24.01%	7.8%	4.48%	5.6%	5.02%	5.53%	5.2%
Debt / Equity	0.22x	0.10x	0.45x	0.14x	0.07x	0.01x	0.09x	0.05x	0.11x	0.11x
Interest Coverage	32.44x	55.86x	29.01x	52.79x	40.32x	46.63x	34.94x	21.84x	19.42x	14.61x
FCF Conversion	1.47x	2.20x	2.24x	1.11x	2.46x	4.46x	4.41x	3.47x	3.48x	1.74x
Revenue Growth	49.66%	39.09%	22.96%	63.61%	-10.85%	18.6%	31.82%	22.54%	20.52%	23.1%

VMD SEC Filings & Documents

Viemed Healthcare, Inc. (VMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 16, 2026·SEC

Material company update

Mar 4, 2026·SEC

10-K Annual Reports

FY 2026

Mar 4, 2026·SEC

FY 2025

Mar 10, 2025·SEC

FY 2024

Mar 6, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 5, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

VMD Frequently Asked Questions

Viemed Healthcare, Inc. (VMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Viemed Healthcare, Inc. (VMD) reported $286.6M in revenue for fiscal year 2025. This represents a 1130% increase from $23.3M in 2014.

Viemed Healthcare, Inc. (VMD) grew revenue by 20.5% over the past year. This is strong growth.

Yes, Viemed Healthcare, Inc. (VMD) is profitable, generating $14.9M in net income for fiscal year 2025 (5.5% net margin).

Dividend & Returns

Viemed Healthcare, Inc. (VMD) has a return on equity (ROE) of 10.8%. This is reasonable for most industries.

Viemed Healthcare, Inc. (VMD) generated $25.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More VMD

Viemed Healthcare, Inc. (VMD) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Viemed Healthcare, Inc.(VMD)Earnings, Financials & Key Ratios

VMD Key Insights

✓Strengths

✗Weaknesses

VMD Price & Volume

VMD Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

VMD Recent Earnings

VMD Peer Comparison

Compare VMD vs Peers

vs LINC

vs ISRG

Compare Top 5

VMD Income Statement

VMD Balance Sheet

VMD Cash Flow Statement

VMD Key Ratios

VMD SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

VMD Frequently Asked Questions

Explore More VMD

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation